Hikmet Hiti-Al
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Transpulmonary Proteome Gradients Identify Pathways Involved in Pulmonary Vascular Disease Due To Heart Failure.
Journal: Circulation. Heart failure
Published: September 23, 2025
Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies.
Journal: Pulmonary circulation
Published: January 20, 2025
Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium.
Journal: Frontiers in cardiovascular medicine
Published: February 25, 2022
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial.
Journal: The Lancet. Respiratory medicine
Published: July 03, 2020
Acute Unloading Effects of Sildenafil Enhance Right Ventricular-Pulmonary Artery Coupling in Heart Failure.
Journal: Journal of cardiac failure
Published: June 26, 2020
Hyperuricemia treatment in acute heart failure patients does not improve their long-term prognosis: A propensity score matched analysis from the AHEAD registry.
Journal: Clinical cardiology
Published: April 08, 2019
Macitentan in pulmonary hypertension due to left ventricular dysfunction.
Journal: The European respiratory journal
Published: September 15, 2017
Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry.
Journal: BMC pulmonary medicine
Published: November 18, 2013
Long-term results from the EARLY study of bosentan in WHO functional class II pulmonary arterial hypertension patients.
Journal: International journal of cardiology
Published: May 29, 2013
The effects of phosphodiesterase 5 inhibition on hemodynamics, functional status and survival in advanced heart failure and pulmonary hypertension: a case-control study.
Journal: International journal of cardiology
Published: February 22, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026